Funding Rounds
Araris Biotech

Araris Biotech Series A (2022, $24M)

Araris Biotech

Developer of an antibody-drug conjugates (ADCs).

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $24.00M

Raised Date: 2022-01-01

Investors